Eldred Rock Partners, LLC Novartis Ag Transaction History
Eldred Rock Partners, LLC
- $239 Billion
- Q2 2024
A detailed history of Eldred Rock Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Eldred Rock Partners, LLC holds 27,727 shares of NVS stock, worth $3.24 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
27,727
Previous 14,379
92.83%
Holding current value
$3.24 Million
Previous $1.39 Billion
112.23%
% of portfolio
1.23%
Previous 0.76%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$868 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$867 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$695 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $252B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...